(20352048), E. N. A., (13955772), R. B., (20352051), A. F., (20352054), A. A., (18112264), A. H., & (20352057), M. E. (2020). Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines.
Chicago Style (17th ed.) Citation(20352048), Eman N Alhmoud, Raja Barazi (13955772), Amr Fahmi (20352051), Abdullah Abdu (20352054), Alya Higazy (18112264), and Maguy ElHajj (20352057). Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines. 2020.
MLA (9th ed.) Citation(20352048), Eman N Alhmoud, et al. Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines. 2020.